Search for: "RANBAXY LABORATORIES INC."
Results 21 - 40
of 75
Sorted by Relevance
|
Sort by Date
28 Jan 2012, 6:23 am
Any hopes that consumers of generic drugs would be protected by the FDA’s own oversight of generic drug manufacturing came to a crashing halt earlier this week when the Department of Justice and the Food and Drug Administration jointly announced their Consent Decree with Ranbaxy Laboratories: Through investigation by the department and the FDA, the government uncovered numerous problems with Ranbaxy’s drug manufacturing and testing in India and at facilities… [read post]
24 May 2021, 7:34 am
The plaintiffs have accused Ranbaxy of delaying the launch of generic versions of Novartis AG’s high blood pressure drug Diovan, Pfizer Inc’s acid reflux drug Nexium and Genentech Inc’s antiviral drug Valcyte. [read post]
28 Jul 2010, 12:06 am
Ranbaxy Laboratories Inc. [read post]
3 Jun 2013, 8:38 am
Next up: another pharmaceutical company, Ranbaxy Laboratories, Ltd. [read post]
27 Jun 2012, 5:38 am
That day has come with Sandoz Inc. [read post]
6 Oct 2010, 4:31 pm
Forest Laboratories, Inc., 527 F.3d 1278 (Fed. [read post]
16 Jun 2010, 3:02 pm
Ranbaxy Laboratories Ltd. et al. [read post]
3 Dec 2006, 10:41 pm
Pfizer shares plunged to about 20 dollars a year ago when Indian drugmaker Ranbaxy Laboratories Inc. said it would produce a generic form of Lipitor. [read post]
26 Apr 2011, 11:15 pm
Ranbaxy Laboratories manufactured an Accutane version called Sotret which has been withdrawn. [read post]
10 Oct 2013, 8:42 am
Ranbaxy USA Inc. ($500 Million) Ranbaxy USA Inc., a subsidiary of Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited, agreed to pay a total of $500 million to settle criminal and civil allegations filed against the company. [read post]
25 Oct 2014, 9:01 pm
., Inc. v. [read post]
3 Mar 2013, 12:06 pm
Patil 337/DELNP/2003 LANXESS DEUTSCHLAND GMBH Granted Dr.Rajesh Dixit 4069/DELNP/2006 RANBAXY LABORATORIES LIMITED Withdrawn Hardev Karar 106/DELNP/2008 ALFA WASSERMANN S. [read post]
6 Oct 2010, 11:43 pm
Forest Laboratories, Inc., 527 F.3d 1278 (Fed. [read post]
18 Aug 2010, 12:19 am
Ranbaxy Laboratories Ltd. et al. [read post]
19 May 2010, 6:15 am
(Patent Docs) US: CAFC affirms claim construction and corresponding summary judgment of non-infringement: Scantibodies Laboratory, Inc. v. [read post]
18 Mar 2010, 2:30 am
Paddock Laboratories, Inc. [read post]
29 Aug 2012, 10:09 pm
., Inc. [read post]
20 Feb 2024, 7:16 am
Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India’s Ranbaxy Laboratories to delay sales of less expensive, generic versions of the cholesterol drug Lipitor. [read post]
18 Feb 2014, 12:43 pm
Ranbaxy Laboratories Ltd., 457 F.3d 1284 (Fed. [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
